A Tumor Microenvironment Dual Responsive Contrast Agent for Contrary Contrast-Magnetic Resonance Imaging and Specific Chemotherapy of Tumors
Yudie Lu,Jie Feng,Zhiyu Liang,Xuanyi Lu,Shuai Guo,Lin Huang,Wei Xiong,Sijin Chen,Huimin Zhou,Xuehua Ma,Yikai Xu,Xiaozhong Qiu,Aiguo Wu,Xiaoyuan Chen,Zheyu Shen
DOI: https://doi.org/10.1039/d1nh00632k
2022-01-01
Nanoscale Horizons
Abstract:Development of magnetic resonance imaging (MRI) contrast agents (CAs) is still one of the research hotspots due to the inherent limitations of T1- or T2-weighted CAs and T1/T2 dual-mode CAs. To dramatically enhance the MRI contrast between tumors and normal tissues, we propose a new concept of contrary contrast-MRI (CC-MRI), whose specific definition is that CC-MRI CAs present a positive or negative signal at normal tissues, but show contrary signals at diseased tissues. To realize CC-MRI of tumors, we designed and developed a tumor microenvironment (TME) dual responsive CA (i.e., SA-FeGdNP-DOX@mPEG), which is almost not responsive under normal physiological conditions, but highly responsive to the acidic and reductive TME. Our SA-FeGdNP-DOX@mPEG shows a negative MRI signal under normal physiological conditions due to the high r2 value (336.9 mM-1 s-1) and high r2/r1 ratio (18.4), but switches to a positive MRI signal in the TME because of the high r1 value (20.32 mM-1 s-1) and low r2/r1 ratio (7.2). Our TME dual responsive SA-FeGdNP-DOX@mPEG significantly enhanced the contrast of MR images between tumors and livers, and the ΔSNR difference reached 501%. In addition, our SA-FeGdNP-DOX2@mPEG2 with tumor targetability and controlled DOX release responding to the TME was also used for tumor-specific chemotherapy with reduced side effects.